2022 remains a pivotal year for Treg directed therapies, with several trials due to read-out, and as we await the much-anticipated clinical proof of concept, the opportunity in this space is exploding as we begin to see the potential of Treg therapies in autoimmune, transplant, and inflammation.
The 4th Treg Directed Therapies Summit returns to Boston bigger and better than ever before, boasting 2 tracks of unparalleled content to cater to cell-based, and non-cell-based experts alike. This is your unique opportunity to unite senior-level executives from key large pharma, biotech, academia and solution providers to discuss how to target Treg-modifying therapies with enhanced persistence and durability safely and at scale.
Event Name: 4th Treg Directed Therapies Summit
Event Venue: Embassy Suites by Hilton, Boston Logan Airport, 207 Porter St,
Boston,MA 02128, United States
Event Date: 17 – 19 May, 2022
Event website link: https://treg-directed-therapies.com/
Event Organizer Name: Hanson Wade
Communication number (with country & area code):+1 617 455 4188
Email ID: info@hansonwade.com
